Cargando…
Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis
BACKGROUND: Due to demographic transition, multimorbidity and high numbers of medicinal products, polypharmacy rates will presumably further increase. This could lead to higher risks of potentially inappropriate medications with potential drug-drug interactions (PDDI). PDDI has already been investig...
Autores principales: | Dornquast, Christina, Dombrowski, Mirja, Zabel, Markus, Willich, Stefan N., Reinhold, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106753/ https://www.ncbi.nlm.nih.gov/pubmed/32234046 http://dx.doi.org/10.1186/s12913-020-05131-7 |
Ejemplares similares
-
Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review
por: Tomzik, Juliane, et al.
Publicado: (2015) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022) -
Prevalence, Mortality, and Indicators of Health Care Supply—Association Analysis of Cardiovascular Diseases in Germany
por: Dornquast, Christina, et al.
Publicado: (2018) -
Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018) -
Implantable cardioverter-defibrillators /
Publicado: (1994)